Brief: Amphastar Pharmaceuticals Inc Says On Nov 15, Co's Unit Entered Into A Supply Agreement With Nanjing Letop Biotechnology Co.
18/11/2022 21:54
Nov 18 (Reuters) - Amphastar Pharmaceuticals Inc
AMPH.O :
* AMPHASTAR PHARMACEUTICALS INC - ON NOVEMBER 15, CO'S UNIT
ENTERED INTO A SUPPLY AGREEMENT WITH NANJING LETOP BIOTECHNOLOGY
CO.
* AMPHASTAR PHARMACEUTICALS -PURSUANT TO DEAL, LETOP TO
MANUFACTURE, DELIVER CHEMICAL INTERMEDIATES FOR UNIT ACCORDING
TO REQUIREMENTS OF PURCHASE ORDERS
Further company coverage: AMPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amphastar Pharmaceuticals,
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
Amphastar Q1 revenue and adjusted EPS miss estimates
Brief: Amphastar Pharmaceuticals Q1 EPS USD 0.14
Brief: Amphastar Pharmaceuticals Inc - Authorizes $50 Million Increase To Share Buyback Program On March 12, 2026 - SEC Filing
Brief: Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3 - SEC Filing